10x Genomics, Inc.
TXG
$26.31
-$0.94-3.45%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.46% | 47.36% | -48.98% | -22.99% | -194.78% |
| Total Depreciation and Amortization | -1.81% | 2.50% | -3.85% | 37.85% | 1.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.04% | 14.58% | -18.09% | 11.32% | 5.15% |
| Change in Net Operating Assets | -136.90% | 5.54% | 262.79% | -66.66% | 69.19% |
| Cash from Operations | -161.05% | 201.79% | -119.54% | -179.42% | -130.06% |
| Capital Expenditure | 15.65% | 77.36% | 39.91% | -456.17% | 88.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.17% | -17.82% | -3.63% | -83.22% | 1,274.03% |
| Cash from Investing | -18.83% | 167.31% | 209.82% | -103.72% | 461.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -70.82% | 28.33% | -38.36% | 195.67% | -52.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.82% | 28.33% | -38.36% | 307.85% | -168.27% |
| Foreign Exchange rate Adjustments | -162.34% | 190.59% | -73.47% | -304.17% | -90.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.86% | 376.43% | -80.24% | -107.95% | 892.01% |
